New York, NY (PRWEB) September 23, 2011
The S.L.E. Lupus Foundation and Lupus Research Institute (LRI) commend the entire U.S. Senate Appropriations Committee for recognizing the urgent need for greater health education in lupus with the adoption of its fiscal 2012 Labor, Health and Human Services and Education appropriations bill September 21. The Senate legislation allocates $1 million to continue the current federal lupus education initiative, aimed at alleviating racial/health disparities by providing healthcare professionals with state-of-the-art training to recognize, diagnose and treat lupus appropriately.
Members of the Senate and House appropriations committees will negotiate a final conference committee bill later this fall to set the ultimate funding levels for 2012.
The language of the Senate bill confirms the pressing need for improved lupus diagnosis and treatment: “The Committee recommendation includes $1,000,000 to continue the national health education program on lupus for healthcare providers. The Committee notes that this debilitating autoimmune disease is up to three times more common among African Americans, Hispanics and Native Americans and affects over 1.5 million persons, 90 percent of whom are women. The Committee continues to support this important national education effort to engage healthcare providers, educators and schools of health professions in working together to improve lupus diagnosis and treatment through education.”
“As a 40-year advocate for lupus patients, the S.L.E. Lupus Foundation and Lupus Research Institute thank Senator Frank Lautenberg (D-NJ) the lead champion for this effort, as well as Labor-HHS Subcommittee Chairman Tom Harkin (D-IA) and Ranking Member Richard Shelby (R-AL) for effectively impressing upon the Senate Appropriations Committee the urgent need for lupus education,” noted CEO Margaret Dowd. “On behalf of the nation’s lupus community, we are grateful to the Committee for recognizing the severity of the problem and providing the necessary funding to address it. Raising awareness of lupus among the full range of healthcare providers will also help accelerate research into treatment and ultimately the cure.”
Affecting more than 1.5 million Americans, lupus is a chronic, complex and prevalent autoimmune disease, in which the body’s immune system creates antibodies that can attack any organ or tissue -- the kidneys, brain, heart, lungs, blood, skin, and joints. Nine out of ten lupus sufferers are women, mostly young women between the ages of 15 to 44, and women of color are especially at risk. There is no one test to diagnose lupus, and because its symptoms can be mistaken for other diseases or conditions, it can take months or years to identify and treat. The healthcare professional training and resource development this bill will afford aims to speed up lupus detection to ensure that patients receive proper treatment as early as possible for the best possible outcomes.
The bill also recommends $4.462 million in FY 2012 funding to support the Centers for Disease Control and Prevention National Lupus Patient Registry “to continue and expand the program to address epidemiological gaps among Hispanics/Latinos, Asian Americans and Native Americans. In addition, a cohort of registry patients will be established to further study long-term outcomes, socio-economic burdens and mortality associated with the disease.”
S.L.E. Lupus Foundation: Science and Service
Founded in 1970, the S.L.E. Lupus Foundation is the country’s preeminent nonprofit organization providing direct patient services, patient and professional education, public awareness and research support. The S.L.E. Lupus Foundation funds lupus research grants and fellowship awards for new investigators in the New York Region and in Southern California, and in partnership with the Lupus Research Institute, supports innovative novel research nationwide. To learn more about lupus and the Foundation, call 800-74-LUPUS or visit http://www.LupusNY.org.
The Lupus Research Institute, Leader in Research Funding
The Lupus Research Institute (LRI), the world’s leading private supporter of innovative research in lupus, pioneers discovery and champions scientific creativity in the hunt for solutions to this complex and dangerous autoimmune disease. Founded by families and shaped by leading scientists, the LRI mandates sound science and rigorous peer review to uncover and support only the highest ranked novel research to prevent, treat and cure lupus.
With its National Coalition of state and local lupus organizations, the LRI is dedicated to finding new and safer options for treating the disease by improving the design of clinical studies and promoting broad participation in clinical trials. Visit http://www.lupusresearchinstitute.org for more information about the Lupus Research Institute.